Literature DB >> 1358988

Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells.

L Romani1, A Mencacci, E Cenci, P Mosci, G Vitellozzi, U Grohmann, P Puccetti, F Bistoni.   

Abstract

Anti-CD4, anti-CD8, or anti-interferon-gamma (IFN-gamma) antibodies or combinations of them were administered in the early stages of chronic infection of mice with a Candida albicans live vaccine strain, and the animals were monitored for course of primary infection, development of delayed-type hypersensitivity, resistance to reinfection, production of interleukin 2 (IL-2) and IFN-gamma in vitro by splenic lymphocytes, and levels of IL-2 and IFN-gamma transcripts in these cells. CD4+ cell and IFN-gamma depletion resulted in the development of fatal candidiasis by the attenuated yeast vaccine. In contrast, either treatment alone modified the course but not the outcome of primary infection, though each prevented the development of resistance to reinfection. Our data thus indicate that both IFN-gamma and CD4+ cells participate in resistance to primary infection with attenuated yeast cells and are critical in the induction of persistent systemic anticandidal immunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358988     DOI: 10.1093/infdis/166.6.1384

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

2.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Authors:  A Mencacci; R Spaccapelo; G Del Sero; K H Enssle; A Cassone; F Bistoni; L Romani
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

5.  Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Authors:  M Wüthrich; H I Filutowicz; B S Klein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages.

Authors:  E Blasi; L Pitzurra; A R Chimienti; R Mazzolla; M Puliti; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; E Schiaffella; L Tonnetti; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.

Authors:  L Romani; P Puccetti; A Mencacci; R Spaccapelo; E Cenci; L Tonnetti; F Bistoni
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.